Skip to main content

Shetty Reshma P.'s Form 4 filing

Ginkgo Bioworks Holdings, Inc. (DNA) · filed Oct 4, 2022

Accession no.
0000899243-22-032859
Filed
Oct 4, 2022, 10:05 PM ET
Trade date
Oct 1, 2021-Oct 3, 2022
Filing delay
368 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 6 non-derivative transactions and 6 derivative transactions. Open-market sales total $2.14M. It was filed 368 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Shetty Reshma P.CIK 0001873523Director, Officer (See Remarks), 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 30, 2022Class A Common StockMOption exerciseAcquired+773,453–F2–773,453DirectDuplicate filing
Sep 30, 2022Class A Common StockMOption exerciseAcquired+773,453–F2–773,453IndirectDuplicate filing
Oct 1, 2021Class A Common StockMOption exerciseAcquired+25,782,354–F3–26,555,807DirectDuplicate filing
Oct 1, 2021Class A Common StockMOption exerciseAcquired+25,782,354–F3–26,555,807IndirectDuplicate filing
Oct 3, 2022Class A Common StockSSaleDisposed−343,071$3.12−$1,070,930.4326,212,736DirectDuplicate filing
Oct 3, 2022Class A Common StockSSaleDisposed−343,072$3.12−$1,070,933.5626,212,735IndirectDuplicate filing

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 30, 2022Class B Common StockMOption exerciseDisposed−773,453–F2–2,320,344DirectDuplicate filing
Sep 30, 2022Class B Common StockMOption exerciseDisposed−773,453–F2–2,320,344IndirectDuplicate filing
Nov 17, 2021Restricted Stock UnitsAGrant or awardAcquired+25,782,354–F3–25,782,354DirectDuplicate filing
Nov 17, 2021Restricted Stock UnitsAGrant or awardAcquired+25,782,354–F3–25,782,354IndirectDuplicate filing
Oct 1, 2022Restricted Stock UnitsMOption exerciseDisposed−25,782,354–F3–0DirectDuplicate filing
Oct 1, 2022Restricted Stock UnitsMOption exerciseDisposed−25,782,354–F3–0IndirectDuplicate filing

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date.

Referenced by the price of 2 transactions in Table I and 2 transactions in Table II.

F3

Represents restricted stock units (the "RSUs") granted prior to the business combination of Soaring Eagle Acquisition Corp. and Ginkgo Bioworks, Inc. in September 2021 (the "Merger"), which became contingent rights to acquire equity securities of the Issuer upon consummation of the Merger. At the time of grant, the RSUs were subject to both a service-based vesting condition and a performance-based vesting condition. On November 17, 2021, the board of directors of the Issuer modified the vesting terms of RSUs, such that the Merger was deemed to have satisfied the performance condition for vesting effective as of March 15, 2022. The service-based vesting condition was satisfied on October 1, 2022, and the Issuer elected to deliver one share of Class A Common Stock for each RSU. Such shares of Class A Common Stock may be exchanged for shares of Class B Common Stock.

Referenced by the price of 2 transactions in Table I and 4 transactions in Table II.

Remarks

President, COO & Founder

Read the full filing on SEC EDGAR (opens in a new tab)